Loading...
7 Immunodeficiencies Reports
Study Period: 2021 - 2030
Regions Covered: North America, South America, Europe, Asia Pacific, Middle East and Africa
Major Players: Abbvie, Pharmacosmos, AMAG (-Covis), Sanofi, Fresenius SE
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Merck, Cipla, Bristol-Myers Squibb, Viatris, Johnson & Johnson
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: GlaxoSmithKline, Pfizer (incl. GBT), Takeda Pharmaceuticals, Amgen, Novartis
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Baxter, Takeda Pharmaceuticals, CSL Behring, Octapharma, Biotest
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific
Major Players: Marinus Pharmaceuticals, Inc, UCB S.A. (Zogenix), Ultragenyx Pharmaceutical Inc., Ovid Therapeutics Inc., Vyant Bio
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Marinus Pharmaceuticals, Zogenix, REGENXBIO, Longboard Pharmaceuticals, Ovid Therapeutics
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Novartis, Gilead Sciences, Bristol-Myers Squibb, Johnson & Johnson, Pfizer
Filter Reports
By Region
By Countries